Annual Accounts Receivable
$734.49 M
-$87.63 M-10.66%
December 31, 2023
Summary
- As of February 7, 2025, GMAB annual accounts receivable is $734.49 million, with the most recent change of -$87.63 million (-10.66%) on December 31, 2023.
- During the last 3 years, GMAB annual accounts receivable has risen by +$327.39 million (+80.42%).
- GMAB annual accounts receivable is now -10.66% below its all-time high of $822.12 million, reached on December 31, 2022.
Performance
GMAB Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$945.12 M
+$59.70 M+6.74%
September 1, 2024
Summary
- As of February 7, 2025, GMAB quarterly accounts receivable is $945.12 million, with the most recent change of +$59.70 million (+6.74%) on September 1, 2024.
- Over the past year, GMAB quarterly accounts receivable has increased by +$175.80 million (+22.85%).
- GMAB quarterly accounts receivable is now -1.48% below its all-time high of $959.29 million, reached on June 30, 2020.
Performance
GMAB Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
GMAB Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.7% | +22.9% |
| 3 y3 years | +80.4% | +101.8% |
| 5 y5 years | +261.3% | +101.8% |
GMAB Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.7% | +43.3% | at high | +121.3% |
| 5 y | 5-year | -10.7% | +80.4% | -1.5% | +466.3% |
| alltime | all time | -10.7% | >+9999.0% | -1.5% | >+9999.0% |
Genmab A/S Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $945.12 M(+6.7%) |
| Jun 2024 | - | $885.43 M(+30.8%) |
| Mar 2024 | - | $676.84 M(-7.8%) |
| Dec 2023 | $734.49 M(-10.7%) | $734.49 M(-4.5%) |
| Sep 2023 | - | $769.33 M(+12.4%) |
| Jun 2023 | - | $684.41 M(+46.2%) |
| Mar 2023 | - | $468.28 M(-43.0%) |
| Dec 2022 | $822.12 M(+60.4%) | $822.12 M(+25.6%) |
| Sep 2022 | - | $654.38 M(+20.3%) |
| Jun 2022 | - | $544.18 M(+27.4%) |
| Mar 2022 | - | $427.08 M(-16.7%) |
| Dec 2021 | $512.58 M(+25.9%) | $512.58 M(+2.3%) |
| Sep 2021 | - | $500.95 M(+28.9%) |
| Jun 2021 | - | $388.72 M(+33.0%) |
| Mar 2021 | - | $292.22 M(-28.2%) |
| Dec 2020 | $407.10 M(-9.2%) | $407.10 M(+26.9%) |
| Sep 2020 | - | $320.87 M(-66.6%) |
| Jun 2020 | - | $959.29 M(+474.8%) |
| Mar 2020 | - | $166.89 M(-62.8%) |
| Dec 2019 | $448.27 M(+120.5%) | $448.27 M(+168.5%) |
| Sep 2019 | - | $166.98 M(+27.5%) |
| Jun 2019 | - | $131.00 M(+23.6%) |
| Mar 2019 | - | $105.99 M(-47.9%) |
| Dec 2018 | $203.28 M(+117.9%) | $203.28 M(+111.1%) |
| Sep 2018 | - | $96.29 M(+13.5%) |
| Jun 2018 | - | $84.84 M(+11.0%) |
| Mar 2018 | - | $76.43 M(-18.1%) |
| Dec 2017 | $93.31 M(-32.8%) | $93.31 M(+54.4%) |
| Sep 2017 | - | $60.44 M(-22.0%) |
| Jun 2017 | - | $77.53 M(+65.8%) |
| Mar 2017 | - | $46.77 M(-66.3%) |
| Dec 2016 | $138.75 M | $138.75 M(+361.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $30.04 M(+38.4%) |
| Jun 2016 | - | $21.70 M(-25.9%) |
| Mar 2016 | - | $29.27 M(+14.4%) |
| Dec 2015 | $25.58 M(+48.1%) | $25.58 M(+130.6%) |
| Sep 2015 | - | $11.09 M(-23.8%) |
| Jun 2015 | - | $14.56 M(+14.8%) |
| Mar 2015 | - | $12.68 M(-26.6%) |
| Dec 2014 | $17.28 M(-31.4%) | $17.28 M(+13.4%) |
| Sep 2014 | - | $15.24 M(-11.8%) |
| Jun 2014 | - | $17.27 M(-57.5%) |
| Mar 2014 | - | $40.66 M(+61.5%) |
| Dec 2013 | $25.17 M(+3.9%) | $25.17 M(+22.3%) |
| Sep 2013 | - | $20.58 M(+21.1%) |
| Jun 2013 | - | $16.99 M(-40.5%) |
| Mar 2013 | - | $28.53 M(+17.7%) |
| Dec 2012 | $24.23 M(+95.2%) | $24.23 M(+103.6%) |
| Jun 2012 | - | $11.90 M(+32.8%) |
| Mar 2012 | - | $8.96 M(-27.8%) |
| Dec 2011 | $12.41 M(+6.3%) | $12.41 M(+14.7%) |
| Sep 2011 | - | $10.82 M(+18.6%) |
| Jun 2011 | - | $9.12 M(+10.3%) |
| Mar 2011 | - | $8.28 M(-29.1%) |
| Dec 2010 | $11.67 M(-41.5%) | $11.67 M(+94.1%) |
| Sep 2010 | - | $6.01 M(-45.7%) |
| Jun 2010 | - | $11.07 M(-52.6%) |
| Mar 2010 | - | $23.37 M(+17.1%) |
| Dec 2009 | $19.96 M(-34.1%) | $19.96 M |
| Dec 2008 | $30.30 M(+318.2%) | - |
| Dec 2006 | $7.25 M(-15.7%) | - |
| Dec 2005 | $8.60 M(+95.4%) | - |
| Dec 2004 | $4.40 M(-11.7%) | - |
| Dec 2003 | $4.98 M(+166.0%) | - |
| Dec 2002 | $1.87 M | - |
FAQ
- What is Genmab A/S annual accounts receivable?
- What is the all time high annual accounts receivable for Genmab A/S?
- What is Genmab A/S annual accounts receivable year-on-year change?
- What is Genmab A/S quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Genmab A/S?
- What is Genmab A/S quarterly accounts receivable year-on-year change?
What is Genmab A/S annual accounts receivable?
The current annual accounts receivable of GMAB is $734.49 M
What is the all time high annual accounts receivable for Genmab A/S?
Genmab A/S all-time high annual accounts receivable is $822.12 M
What is Genmab A/S annual accounts receivable year-on-year change?
Over the past year, GMAB annual accounts receivable has changed by -$87.63 M (-10.66%)
What is Genmab A/S quarterly accounts receivable?
The current quarterly accounts receivable of GMAB is $945.12 M
What is the all time high quarterly accounts receivable for Genmab A/S?
Genmab A/S all-time high quarterly accounts receivable is $959.29 M
What is Genmab A/S quarterly accounts receivable year-on-year change?
Over the past year, GMAB quarterly accounts receivable has changed by +$175.80 M (+22.85%)